Vironova BioAnalytics proudly stands as the only global provider of GMP-certified TEM services. Our operations are driven by our proprietary AI software, fully compliant with FDA 21 CFR Part 11, which serves as a robust foundation, ensuring superior quality control in the development of therapeutic nanoparticles and viral vectors. Our unique analytical approach offers efficient, unbiased, and precise therapeutic nanoparticle analysis, operating from the heart of our Stockholm, Sweden headquarters. This facility has the distinction of being the world's only GMP-certified TEM-BSLII lab. As your trusted partner, we leverage over a decade of experience and robust analytics to bolster the value of your product, fine-tune decision-making, and place patient safety at the forefront on a global scale.
Stay ahead in the industry with Vironova's latest updates and innovations. Don't miss out – follow us on social media and subscribe to our newsletter for the most recent trends and breakthroughs!
You can also follow us on Mynewsdesk for relevant news updates.